Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Active not recruiting 2Terminated 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 3

Sponsor

Cancer Type

Tumor-Agnostic 1Other hematologic neoplasm 1

Conditions

Neoplasms 2Hematologic Neoplasms 1Depression 1Death 1Cancer Patients 1

Interventions

Specimen Handling 613pembrolizumab 583Magnetic Resonance Spectroscopy 543Carboplatin 430Cyclophosphamide 380Cisplatin 377Biopsy 366Paclitaxel 314Nivolumab 312Gemcitabine 308Radiotherapy 268Bevacizumab 230Dexamethasone 217fludarabine 205Docetaxel 190durvalumab 188venetoclax 187Oxaliplatin 187Rituximab 174Fluorouracil 174atezolizumab 169Pemetrexed 166Capecitabine 162Radiosurgery 160Doxorubicin 160Radiation 156Ipilimumab 144Lenalidomide 140Leucovorin 138Etoposide 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Focus Groups × 90 days × Clear all
NCT06786104 2026-05-14

VIDEO-PEDS

Massachusetts General Hospital

Phase NA Recruiting
567 enrolled

Death, Neoplasms

NCT05012124 2026-04-16

Using Technology to Optimize Collaborative Care Management of Depression in Urban and Rural Cancer Centers, SCOPE

University of Washington

Phase NA Terminated
297 enrolled
Other hematologic neoplasm

Depression, Hematologic Neoplasms

NCT01603316 2026-03-12

Food: A Three-Arm Study Examining Food Insecurity Interventions

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
606 enrolled

Cancer Patients

NCT06549153 2026-03-09

ACT-Together (Acting on Cancer Testing-Together)

M.D. Anderson Cancer Center

Phase NA Active not recruiting
30 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡